TY - JOUR
T1 - Canakinumab for Atherosclerotic Disease
JO - The New England journal of medicine
UR - http://eprints.whiterose.ac.uk/126384/
PY - 2018/01/11
AU - Rothman AMK
AU - Morton AC
AU - Crossman DC
AU - Investigators MRC-ILAH
ED -
DO - DOI: 10.1056/NEJMc1714635
PB - Massachusetts Medical Society
VL - 378
IS - 2
SP - 196
EP - 200
Y2 - 2025/01/07
ER -